Blood platelets are crucial to prevent excessive bleeding following injury to blood vessels. Platelets are crucial for the formation of clots and for clot strength. Platelet activation involves aggregation, attachment to fibrin and clot retraction. Most assays that address platelet function measure platelet aggregation, not clot retraction. Here, we describe a 96-well-based clot retraction assay that requires a relatively short runtime and small sample volume. The assay involves continuous optical density monitoring of platelet-rich plasma that is activated with thrombin. The data can be analyzed using time-series analytical tools to generate quantitative information about different phases of clot formation and clot retraction. The assay demonstrated good repeatability and reproducibility and was robust to different calcium concentrations. Impairment of platelet bioenergetics, actin polymerization, fibrin interaction, and signaling significantly affected clot retraction and was detected and showed good agreement with light transmission aggregometry, suggesting that clot retraction is predictive of platelet function. Using this microplate clot retraction assay, we showed a significant difference in platelets stored in autologous plasma compared with platelet additive solution after 7 days of room temperature storage.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/09537104.2023.2254403 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a simplified platelet cryopreservation method: An in vitro investigation of reducing the DMSO concentration to allow administration without its pre-transfusion removal.
Vox Sang
January 2025
Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.
Background And Objectives: The most widely used method of platelet cryopreservation requires the addition of 5%-6% dimethylsulphoxide (DMSO), followed by its pre-freeze removal via centrifugation, to minimize toxicity. However, this adds complexity to the pre-freeze and post-thaw processing. Accordingly, the aim of this study was to simplify platelet cryopreservation by reducing the DMSO concentration and omitting the requirement for pre-transfusion removal.
View Article and Find Full Text PDFSpatial and temporal characterization of cytoskeletal reorganizations in adherent platelets.
Platelets
December 2024
Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France.
The functional role of platelets is intricately linked to the dynamic organization of two main components of the cytoskeleton, microtubules and actin fibers. Throughout the phases of platelet activation, spreading, and retraction, both of these essential polymers undergo continuous and orchestrated reorganization. Our investigation of the dynamic cytoskeletal changes during these phases highlights a sequential remodeling of the actin cytoskeleton in adherent platelets from the formation of initial actin nodules through the development of stress fibers and a subsequent return to nodular structures.
View Article and Find Full Text PDFCompact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.
Cureus
October 2024
Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, USA.
Article Synopsis
- - Hemorrhage is the main cause of preventable death in trauma situations, leading to military and civilian advancements in medical practices, particularly through the use of tourniquets to manage extremity bleeding and save lives.
- - While tourniquets have significantly decreased deaths from bleeding in military settings, noncompressible hemorrhage still poses a major risk, especially before patients receive definitive medical care.
- - The study explores using a small, disposable pressure monitor during resuscitative endovascular balloon occlusion of the aorta (REBOA) to enhance blood pressure monitoring, facilitate better resuscitation practices, and reduce the need for blood products in extreme environments.
Unbiased High-Throughput Screening of Drug-Repurposing Libraries Identifies Small-Molecule Inhibitors of Clot Retraction.
Blood Adv
October 2024
Rockefeller University, New York, New York, United States.
Article Synopsis
- Platelet clot retraction plays a crucial role in stabilizing clots and requires functional αIIbβ3 receptors and fibrin, along with the platelet cytoskeleton's contractile activity.
- Recent research found that even when platelet aggregation is blocked using the αIIbβ3 antagonist RGDW, clot retraction still occurs, leading to the development of a high-throughput assay to identify small molecule inhibitors of this process.
- A screening of over 9,700 compounds revealed 27 inhibitors of clot retraction, including established antiplatelet drugs and new compounds, with further studies suggesting these may have unique mechanisms to inhibit thrombosis.
Platelet integrin αIIbβ3 plays a key role in a venous thrombogenesis mouse model.
Nat Commun
October 2024
Division of Nephrology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Article Synopsis
- Venous thrombosis (VT) is a serious vascular condition that can lead to decreased survival rates and frequent recurrences, primarily initiated by platelet and neutrophil accumulation at activated endothelial sites.
- The study highlights a new drug, m-tirofiban, which does not activate the platelet receptor αIIbβ3, unlike its predecessor tirofiban, thus avoiding the risk of increased bleeding while effectively suppressing VT in mouse models.
- These results suggest that m-tirofiban and similar compounds could be promising candidates for preventing VT in patients at high risk, balancing efficacy with safety.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!